Clinical Trials Directory

Trials / Completed

CompletedNCT02802189

The Effect of Integrated Neuromuscular Inhibition Technique in Combination With Therapeutic Exercise on Patients With Chronic Mechanical Neck Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the combine effect of the integrated neuromuscular inhibition technique (soft tissue mobilization techniques protocol), in combination with the therapeutic exercise in patients with chronic mechanical neck pain in the sub-acute stage of symptoms, and to determine whether this combination substantially helps the faster and more efficient installation of adaptations of exercising.

Detailed description

Neck pain is one of the most common and costly musculoskeletal disorders in Western societies, which witnesses high prevalence of repeatability and chronicity. In chronic mechanical neck pain, there are changes in the neck area, due to muscular imbalance between deep neck flexors (longus capitis and longus colli) and superficial flexors of the neck (sternocleidomastoid and anterior scalene). Therapeutic exercise plays a key role in the restoration of this muscle imbalance, comprising a combination of resistant and endurance training. The integrated neuromuscular inhibition technique (INIT) is a manual deactivation trigger points technique and includes the application of ischemic pressure and stretch, the muscle energy technique and the Strain-counterstrain technique. The aim of the research is to investigate whether the application of INIT combined with exercise can reduce the time required to establish the benefits of training and improve faster and to a greater extent the clinical figure and the quality of life of patients with chronic neck pain. Method. Single blind clinical trial lasting for 10 weeks, 40 participants (men/women) with chronic mechanical neck pain. Participants will be divided into two groups, following the same exercise program. The first group (experimental) will follow the exercise programme in combination with the integrated neuromuscular inhibition technique (INIT), while the second (active comparator) will apply the same program excluding the INIT technique. The subjective perception of pain by the visual analogue scale, the functionality related to neck pain with neck disability index, ppt of the neck muscles with pressure algometry, active range of motion with a bubble inclinometer, maximum isometric strength of neck muscles with a hand dynamometer, muscular fatigue of the flexors of the neck with special tests and the quality of life with the sf-36 questionnaire will be evaluated before, during and after the intervention, while follow-ups will take place one, three and six months later.

Conditions

Interventions

TypeNameDescription
OTHERExercise programmeEndurance and Resistant training exercise program (Duration: 45 minutes) * Muscle retraining of longus colli and endurance training of the deep cervical flexors. * Resistant exercises for the muscles involved in neck flexion, extension, side bending and rotation of the neck region. Isometric contractions exercises (20-70% of MVC) and resistant exercises (12-15RM). * Active ROM exercises for the neck muscles * Upper limbs exercises with resistant bands * Stretching exercises for the neck and upper limbs muscles
OTHERIntegrated Neuromuscular Inhibition Technique application.Integrated Neuromuscular Inhibition Technique application. (Duration: 15min) The protocol was applied to the following muscles: * Upper border of the trapezius muscle * sternocleidomastoid * levator scapulae muscle * splenius capitis muscle Integrated Neuromuscular Inhibition Technique includes the combination of the following technique: * Ischemic compression * Muscle energy technique * Strain-counterstrain technique

Timeline

Start date
2016-06-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2016-06-16
Last updated
2017-06-28

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT02802189. Inclusion in this directory is not an endorsement.